The future tailoring of MM treatment
What novel technologies are available for myeloma?
Key studies on multiple myeloma presented at ASH 2016
Escalating doses and improving outcomes in cutaneous T-cell lymphomas
ABL001 – a new BCR-ABL inhibitor for chronic myeloid leukemia (CML) treatment